July 2011 - Vol. 8 No. 7 - Page #36In the continuous effort to comply with USP <797> and The Joint Commission’s National Patient Safety Goals, pharmacists are seeking products that save time and labor while maximizing patient safety. Ready-to-use IV products are often cited as a means to meet those ends, as they eliminate the need to perform compounding and, therefore, can reduce the potential for medication errors and product contamination. To help you increase efficiency and improve patient safety, PP&P presents the following resource for finding ready-to-use IV products. To request more information on any of the products listed in the chart below, visit www.pppmag.com/info
- I like it
- I do not like it
- April 2012 : State of Pharmacy Compounding
Survey Respondents: BONUS DATA - April 2012 : State of Pharmacy Compounding
<797> Compliance: BONUS DATA - April 2012 : State of Pharmacy Compounding
Ready-to-Use IV Products: BONUS DATA - April 2012 : State of Pharmacy Compounding
Budgeting and Renovation: BONUS DATA - April 2012 : State of Pharmacy Compounding
State Regulations Impact USP <797> Compliance

- In The Loop!
- Digital Edition
- Special Announcements








Our mission is to provide health system pharmacists with information to streamline pharmacy operations and promote patient safety.